FASLODEX Side Effects

7002471-3 | Head Injury, Hypokalaemia
on Sep 09, 2010 Female patient from UNITED KINGDOM , weighting 121.3 lb, was diagnosed with breast cancer metastatic, benign endocrine neoplasm and was treated with Faslodex (View Usage). Patient experienced the following unwanted or unexpected effects: head injury, hypokalaemia. Faslodex dosage: . During the same period patient was treated with LETROZOLE (View Letrozole Review and Letrozole Label ), IBANDRONATE SODIUM (View Ibandronate Sodium Review and Ibandronate Sodium Label ). Patient was hospitalized.

6944813-0 | Circulatory Collapse, Cough, Dyspnoea
Patient was taking Faslodex (View Usage). Patient had the following side effects: circulatory collapse, cough, dyspnoea on Aug 20, 2010 from GERMANY Additional patient health information: Female patient , 70 years of age, weighting 134.5 lb, was diagnosed with breast cancer metastatic and. Faslodex dosage: .

6944805-1 | Osteonecrosis Of Jaw
Adverse event was reported on Aug 18, 2010 by a Female patient taking Faslodex (View Usage) (Dosage: ) . Location: GERMANY , 74 years of age, After Faslodex was administered, patient had the following side effects: osteonecrosis of jaw. During the same period patient was treated with CORTISONE ACETATE (View Cortisone Acetate Review and Cortisone Acetate Label ).

6933708-4 | Anxiety, Cough, Dysgeusia, Dyspnoea, Flushing
on Aug 11, 2010 Female patient from UNITED STATES , weighting 95.02 lb, was diagnosed with breast cancer stage iv and was treated with Faslodex (View Usage). Patient experienced the following unwanted or unexpected effects: anxiety (What is anxiety?), cough, dysgeusia, dyspnoea, flushing. Faslodex dosage: .


6914512-X | Anaemia, Coombs Test Positive, Haemolytic Anaemia, Pancytopenia
on Aug 05, 2010 Female patient from UNITED STATES , 62 years of age, was diagnosed with breast cancer metastatic and was treated with Faslodex (View Usage). Patient had the following side effects: anaemia, coombs test positive, haemolytic anaemia, pancytopenia. Faslodex dosage: . During the same period patient was treated with COZAAR (View Cozaar Review and Cozaar Label ), DIGOXIN (View Digoxin Review and Digoxin Label ), GLYBURIDE AND METFORMIN HYDROCHLORIDE (2.5/500 Mg One Tablet Two Times A Day) (View Glyburide And Metformin Hydrochloride Review and Glyburide And Metformin Hydrochloride Label ), OMEPRAZOLE (View Omeprazole Review and Omeprazole Label ), LEVOTHYROXINE SODIUM (View Levothyroxine Sodium Review and Levothyroxine Sodium Label ), VITAMIN D (2000 Units One Daily) (View Vitamin D Review and Vitamin D Label ).

6894410-0 | Benign Bone Neoplasm, Bone Neoplasm Malignant, Bone Pain, Dyspnoea, Fungal Infection, Hot Flush, Nausea, Pharyngitis
Patient was taking Faslodex (View Usage). After Faslodex was administered, patient had the following side effects: benign bone neoplasm, bone neoplasm malignant, bone pain, dyspnoea, fungal infection (What is fungal infection?), hot flush, nausea (What is nausea?), pharyngitis on Jul 22, 2010 from UNITED STATES Additional patient health information: Female patient , 69 years of age, weighting 140.0 lb, was diagnosed with recurrent cancer, breast cancer metastatic, thrombosis, pain (What is pain?) and. Faslodex dosage: . During the same period patient was treated with COUMADIN (View Coumadin Review and Coumadin Label ), ZOMETA (View Zometa Review and Zometa Label ), HYDROCODONE BITARTRATE (View Hydrocodone Bitartrate Review and Hydrocodone Bitartrate Label ), XYCODONE (View Xycodone Review and Xycodone Label ), LYRICA (View Lyrica Review and Lyrica Label ). Patient was hospitalized.

6839372-7 | Osteonecrosis Of Jaw
Adverse event was reported on Jul 06, 2010 by a Female patient taking Faslodex (View Usage) (Dosage: ) . Location: GERMANY , 74 years of age, Patient experienced the following unwanted or unexpected effects: osteonecrosis of jaw. During the same period patient was treated with CORTISONE (View Cortisone Review and Cortisone Label ).

6836215-2 | Contusion
on Jul 07, 2010 Female patient from UNITED KINGDOM , 57 years of age, was diagnosed with breast cancer (What is breast cancer?) and was treated with Faslodex (View Usage). Patient had the following side effects: contusion. Faslodex dosage: . During the same period patient was treated with 5 FLU (View 5-flu Review and 5-flu Label ), CYCLOPHOSPHAMIDE (View Cyclophosphamide Review and Cyclophosphamide Label ), EPIRUBICIN (View Epirubicin Review and Epirubicin Label ), LETROZOLE (View Letrozole Review and Letrozole Label ), TAMOXIFEN (View Tamoxifen Review and Tamoxifen Label ), TOREMIFENE (View Toremifene Review and Toremifene Label ).

6814306-X | Pulmonary Embolism
on Jun 29, 2010 Female patient from GERMANY , weighting 220.5 lb, was diagnosed with breast cancer (What is breast cancer?) and was treated with Faslodex (View Usage). After Faslodex was administered, patient had the following side effects: pulmonary embolism (What is pulmonary embolism?). Faslodex dosage: . Patient was hospitalized and became disabled.

6802698-7 | Anaemia, Arrhythmia
Patient was taking Faslodex (View Usage). Patient experienced the following unwanted or unexpected effects: anaemia, arrhythmia (What is arrhythmia?) on Jun 18, 2010 from GERMANY Additional patient health information: Female patient , weighting 158.7 lb, was diagnosed with breast cancer metastatic, hypertension and. Faslodex dosage: . During the same period patient was treated with ENALAPRIL MALEATE (View Enalapril Maleate Review and Enalapril Maleate Label ), BISO LICH (View Biso-lich Review and Biso-lich Label ), TORASEMIDE (View Torasemide Review and Torasemide Label ). Patient was hospitalized.

6795236-9 | Blood Pressure Increased, Dyspnoea, Hypersensitivity
Adverse event was reported on Jun 16, 2010 by a Female patient taking Faslodex (View Usage) (Dosage: ) was diagnosed with breast cancer metastatic and. Location: FINLAND , 52 years of age, Patient had the following side effects: blood pressure increased, dyspnoea, hypersensitivity. During the same period patient was treated with BONDRONAT (View Bondronat Review and Bondronat Label ), VERPAMIL (View Verpamil Review and Verpamil Label ). Patient was hospitalized.

6782720-7 | Carbohydrate Antigen 27.29 Increased, Metastases To Bone, Metastases To Spine
on Jun 11, 2010 Female patient from UNITED STATES , 81 years of age, was diagnosed with breast cancer (What is breast cancer?) and was treated with Faslodex (View Usage). After Faslodex was administered, patient had the following side effects: carbohydrate antigen 27.29 increased, metastases to bone, metastases to spine. Faslodex dosage: . During the same period patient was treated with CRESTOR (View Crestor Review and Crestor Label ), SYNTHROID (View Synthroid Review and Synthroid Label ), BENAZEPRIL HYDROCHLORIDE (View Benazepril Hydrochloride Review and Benazepril Hydrochloride Label ), ASPIRIN (View Aspirin Review and Aspirin Label ).

6764041-1 | Abdominal Discomfort, Asthenia, Fatigue, Influenza Like Illness, Pyrexia
on Jun 15, 2009 Female patient from UNITED STATES , 77 years of age, weighting 140.0 lb, was treated with Faslodex (View Usage). Patient experienced the following unwanted or unexpected effects: abdominal discomfort, asthenia, fatigue, influenza like illness, pyrexia. Faslodex dosage: . During the same period patient was treated with BETA BLOCKER (View Beta Blocker Review and Beta Blocker Label ), CALCIUM CHANNEL BLOCKERS (View Calcium Channel Blockers Review and Calcium Channel Blockers Label ).

6764040-X | Myositis
Patient was taking Faslodex (View Usage). Patient had the following side effects: myositis (What is myositis?) on Nov 13, 2009 from UNITED STATES Additional patient health information: Female patient , 70 years of age, was diagnosed with breast cancer (What is breast cancer?), bone neoplasm malignant and. Faslodex dosage: 250 Mg/5 Ml Monthly.

6764039-3 | Pruritus
Adverse event was reported on Aug 28, 2009 by a Female patient taking Faslodex (View Usage) (Dosage: ) . Location: UNITED STATES , 76 years of age, weighting 110.0 lb, After Faslodex was administered, patient had the following side effects: pruritus.

6764036-8 | Headache, Lymphadenopathy
on May 27, 2009 Female patient from UNITED STATES , 63 years of age, was treated with Faslodex (View Usage). Patient experienced the following unwanted or unexpected effects: headache (What is headache?), lymphadenopathy. Faslodex dosage: . During the same period patient was treated with HCTZ (View Hctz Review and Hctz Label ), FOSAMAX (View Fosamax Review and Fosamax Label ). Patient was hospitalized.

6764035-6 | Joint Swelling
on Aug 05, 2009 Female patient from UNITED STATES , 64 years of age, weighting 170.0 lb, was diagnosed with breast cancer (What is breast cancer?) and was treated with Faslodex (View Usage). Patient had the following side effects: joint swelling. Faslodex dosage: .

6764033-2 | Blood Glucose Increased, Hepatic Neoplasm Malignant, Injection Site Discomfort, Lung Neoplasm Malignant, Metastases To Lymph Nodes
Patient was taking Faslodex (View Usage). After Faslodex was administered, patient had the following side effects: blood glucose increased, hepatic neoplasm malignant, injection site discomfort, lung neoplasm malignant, metastases to lymph nodes on Nov 19, 2009 from UNITED STATES Additional patient health information: Female patient , 72 years of age, weighting 123.9 lb, was diagnosed with breast cancer recurrent, hypertension, osteoporosis (What is osteoporosis?), blood cholesterol increased and. Faslodex dosage: Every Four Weeks. During the same period patient was treated with ARIMIDEX (View Arimidex Review and Arimidex Label ), AVAPRO (View Avapro Review and Avapro Label ), ALENDRONATE SODIUM (View Alendronate Sodium Review and Alendronate Sodium Label ), LIPITOR (View Lipitor Review and Lipitor Label ).

6764029-0 | Abdominal Pain Upper, Fatigue, Hot Flush, Influenza Like Illness, Malaise
Adverse event was reported on May 22, 2009 by a Female patient taking Faslodex (View Usage) (Dosage: ) . Location: UNITED STATES , 42 years of age, Patient experienced the following unwanted or unexpected effects: abdominal pain upper, fatigue, hot flush, influenza like illness, malaise. During the same period patient was treated with NOLVADEX (View Nolvadex Review and Nolvadex Label ).

6764027-7 | Dizziness, Erythema, Eye Pruritus, Hypoaesthesia
on Oct 05, 2009 Female patient from UNITED STATES , 71 years of age, was diagnosed with breast cancer (What is breast cancer?) and was treated with Faslodex (View Usage). Patient had the following side effects: dizziness (What is dizziness?), erythema, eye pruritus, hypoaesthesia. Faslodex dosage: 6 Injections. During the same period patient was treated with FOSAMAX (View Fosamax Review and Fosamax Label ), PREDNISONE (View Prednisone Review and Prednisone Label ), DILTIAZEM (View Diltiazem Review and Diltiazem Label ), DUONEB (View Duoneb Review and Duoneb Label ), OXYGEN AT NIGHT (View Oxygen At Night Review and Oxygen At Night Label ).

6764026-5 | Faeces Pale, Nausea, Restless Legs Syndrome, Vulvovaginal Dryness
on Apr 30, 2009 Female patient from UNITED STATES , 79 years of age, weighting 147.0 lb, was treated with Faslodex (View Usage). After Faslodex was administered, patient had the following side effects: faeces pale, nausea (What is nausea?), restless legs syndrome, vulvovaginal dryness. Faslodex dosage: . During the same period patient was treated with ACIPHEX (View Aciphex Review and Aciphex Label ).

6764023-X | Injection Site Anaesthesia, Injection Site Discolouration, Injection Site Haematoma, Injection Site Pain, Injection Site Pruritus
Patient was taking Faslodex (View Usage). Patient experienced the following unwanted or unexpected effects: injection site anaesthesia, injection site discolouration, injection site haematoma, injection site pain, injection site pruritus on Aug 25, 2009 from UNITED STATES Additional patient health information: Female patient , 57 years of age, weighting 179.9 lb, was diagnosed with breast cancer (What is breast cancer?) and. Faslodex dosage: . During the same period patient was treated with CRESTOR (View Crestor Review and Crestor Label ), AMBIEN (View Ambien Review and Ambien Label ), ACIPHEX (View Aciphex Review and Aciphex Label ), VITAMIN D (View Vitamin D Review and Vitamin D Label ), AZINEX (View Azinex Review and Azinex Label ), VOLTAREN (View Voltaren Review and Voltaren Label ).

6764022-8 | Arthritis, Back Pain, Hot Flush, Injection Site Scar, Thyroid Disorder
Adverse event was reported on Jun 15, 2009 by a Female patient taking Faslodex (View Usage) (Dosage: ) was diagnosed with breast cancer stage iii, thyroid disorder, hypertension and. Location: UNITED STATES , 67 years of age, weighting 145.1 lb, Patient had the following side effects: arthritis (What is arthritis?), back pain (What is back pain?), hot flush, injection site scar, thyroid disorder. During the same period patient was treated with TRYROID (View Tryroid Review and Tryroid Label ), DYAZIDE (View Dyazide Review and Dyazide Label ).

6764020-4 | Personality Change
on Nov 16, 2009 Female patient from UNITED STATES , 60 years of age, weighting 207.9 lb, was treated with Faslodex (View Usage). After Faslodex was administered, patient had the following side effects: personality change. Faslodex dosage: 2 Doses. During the same period patient was treated with ACTOS (View Actos Review and Actos Label ), AVAPRO (View Avapro Review and Avapro Label ), CLARITIN (View Claritin Review and Claritin Label ), CO Q 10 (View Co-q-10 Review and Co-q-10 Label ), CRESTOR (View Crestor Review and Crestor Label ), DEPRO PEN XL (View Depro Pen-xl Review and Depro Pen-xl Label ), GENUMET (View Genumet Review and Genumet Label ), GLIMEPIRIDE (View Glimepiride Review and Glimepiride Label ).

6764019-8 | Back Pain, Constipation, Gastrooesophageal Reflux Disease, Musculoskeletal Pain, Nausea
on Sep 28, 2009 Female patient from UNITED STATES , 79 years of age, weighting 155.0 lb, was diagnosed with breast cancer metastatic and was treated with Faslodex (View Usage). Patient experienced the following unwanted or unexpected effects: back pain (What is back pain?), constipation (What is constipation?), gastrooesophageal reflux disease, musculoskeletal pain, nausea (What is nausea?). Faslodex dosage: .

6764017-4 | Blood Pressure Increased
Patient was taking Faslodex (View Usage). Patient had the following side effects: blood pressure increased on May 28, 2009 from UNITED STATES Additional patient health information: Female patient , 77 years of age, weighting 128.1 lb, was diagnosed with hypertension, osteoporosis (What is osteoporosis?) and. Faslodex dosage: . During the same period patient was treated with PROPRANOLOL (View Propranolol Review and Propranolol Label ), LISINOPRIL (View Lisinopril Review and Lisinopril Label ), CALTRATE (View Caltrate Review and Caltrate Label ), ALENDRONATE SODIUM (View Alendronate Sodium Review and Alendronate Sodium Label ).

6764015-0 | Psoriasis
Adverse event was reported on Feb 25, 2010 by a Female patient taking Faslodex (View Usage) (Dosage: ) was diagnosed with breast cancer stage iv and. Location: UNITED STATES , 66 years of age, weighting 160.1 lb, After Faslodex was administered, patient had the following side effects: psoriasis. During the same period patient was treated with VITAMINS (View Vitamins Review and Vitamins Label ).

6764014-9 | Haematoma
on Sep 28, 2009 Female patient from UNITED STATES , 68 years of age, was diagnosed with breast cancer (What is breast cancer?) and was treated with Faslodex (View Usage). Patient experienced the following unwanted or unexpected effects: haematoma. Faslodex dosage: .

6764012-5 | Asthenia, Balance Disorder, Fatigue
on Oct 13, 2009 Female patient from UNITED STATES , weighting 125.0 lb, was diagnosed with breast cancer (What is breast cancer?) and was treated with Faslodex (View Usage). Patient had the following side effects: asthenia, balance disorder, fatigue. Faslodex dosage: Monthly. During the same period patient was treated with ARIMIDEX (View Arimidex Review and Arimidex Label ), PRILOSEC (View Prilosec Review and Prilosec Label ), PEPCID (View Pepcid Review and Pepcid Label ).

6764011-3 | Neuropathy Peripheral
Patient was taking Faslodex (View Usage). After Faslodex was administered, patient had the following side effects: neuropathy peripheral on Feb 25, 2010 from UNITED STATES Additional patient health information: Female patient , weighting 130.5 lb, was diagnosed with breast cancer (What is breast cancer?) and. Faslodex dosage: .

6742287-6 | Bone Neoplasm Malignant, Bone Pain, Dyspnoea, Hot Flush, Hypoaesthesia
Adverse event was reported on May 17, 2010 by a Female patient taking Faslodex (View Usage) (Dosage: ) was diagnosed with recurrent cancer and. Location: UNITED STATES , 67 years of age, Patient experienced the following unwanted or unexpected effects: bone neoplasm malignant, bone pain, dyspnoea, hot flush, hypoaesthesia. During the same period patient was treated with COUMADIN (View Coumadin Review and Coumadin Label ), ZOMETA (View Zometa Review and Zometa Label ).

6676200-7 | Injection Site Reaction, Nausea
on Apr 07, 2010 Female patient from UNITED KINGDOM , 69 years of age, was diagnosed with breast cancer metastatic, deep vein thrombosis (What is deep vein thrombosis?), hypertension and was treated with Faslodex (View Usage). Patient had the following side effects: injection site reaction, nausea (What is nausea?). Faslodex dosage: 250 Mg. During the same period patient was treated with DEXAMETHASONE (2 Mg) (View Dexamethasone Review and Dexamethasone Label ), FRAGMIN (18000 Iu) (View Fragmin Review and Fragmin Label ), FUROSEMIDE (40 Mg) (View Furosemide Review and Furosemide Label ), SPIRONOLACTONE (50 Mg) (View Spironolactone Review and Spironolactone Label ).

6671638-6 | Diarrhoea, Hyperpyrexia, Hypokalaemia, Vomiting
on Mar 31, 2010 Female patient from ITALY , weighting 123.5 lb, was diagnosed with breast cancer metastatic, depression (What is depression?), hypertension and was treated with Faslodex (View Usage). After Faslodex was administered, patient had the following side effects: diarrhoea, hyperpyrexia, hypokalaemia, vomiting. Faslodex dosage: 250 Mg On Day 1,14 And 28, Then Maintenance Dose 250 Mg Monthly. During the same period patient was treated with XANAX (View Xanax Review and Xanax Label ), ENAPREN (View Enapren Review and Enapren Label ), TENORMIN (View Tenormin Review and Tenormin Label ). Patient was hospitalized.

6671067-5 | Abdominal Pain, Amnesia, Arthralgia, Constipation, Decreased Appetite, Dyskinesia, Dysphonia, Feeling Abnormal, Hot Flush
Patient was taking Faslodex (View Usage). Patient experienced the following unwanted or unexpected effects: abdominal pain (What is abdominal pain?), amnesia, arthralgia, constipation (What is constipation?), decreased appetite, dyskinesia, dysphonia, feeling abnormal, hot flush on Mar 29, 2010 from UNITED STATES Additional patient health information: Female patient , 71 years of age, weighting 147.9 lb, was diagnosed with breast cancer metastatic and. Faslodex dosage: Monthly; 2nd Dose Was 1/2 Of An Injection; Considering Full Dose For 3rd Dose. During the same period patient was treated with ZOLOFT (View Zoloft Review and Zoloft Label ), LEVOTHYROXINE SODIUM (View Levothyroxine Sodium Review and Levothyroxine Sodium Label ).

6603229-7 | Abdominal Pain, Amnesia, Constipation, Decreased Appetite, Dyskinesia, Dysphonia, Feeling Abnormal, Hot Flush, Hyperhidrosis
Adverse event was reported on Feb 17, 2010 by a Female patient taking Faslodex (View Usage) (Dosage: Monthly; 2nd Dose Was 1/2 Of An Injection; Considering Full Dose For 3rd Dose) was diagnosed with breast cancer metastatic and. Location: UNITED STATES , 71 years of age, weighting 147.9 lb, Patient had the following side effects: abdominal pain (What is abdominal pain?), amnesia, constipation (What is constipation?), decreased appetite, dyskinesia, dysphonia, feeling abnormal, hot flush, hyperhidrosis. During the same period patient was treated with ZOLOFT (View Zoloft Review and Zoloft Label ), LEVOTHYROXINE (View Levothyroxine Review and Levothyroxine Label ).

6601883-7 | Hepatic Neoplasm
on Feb 17, 2010 Female patient from AUSTRIA , weighting 178.6 lb, was diagnosed with breast cancer metastatic, nervousness, parkinson's disease (What is parkinson's disease?), angiopathy, depression (What is depression?), sleep disorder (What is sleep disorder?), maculopathy, pain (What is pain?) and was treated with Faslodex (View Usage). After Faslodex was administered, patient had the following side effects: hepatic neoplasm. Faslodex dosage: . During the same period patient was treated with NEUROMULTIVIT (Two Times A Day) (View Neuromultivit Review and Neuromultivit Label ), SELEGILIN (View Selegilin Review and Selegilin Label ), NICERGIN (Every Morning) (View Nicergin Review and Nicergin Label ), CIPRALEX (View Cipralex Review and Cipralex Label ), TRAZODONE HCL (View Trazodone Hcl Review and Trazodone Hcl Label ), LUTIMAX (View Lutimax Review and Lutimax Label ), DURAGESIC 100 (75 Ug/h Every Three Days) (View Duragesic-100 Review and Duragesic-100 Label ), HYDAL (View Hydal Review and Hydal Label ). Patient was hospitalized.

6596566-6 | Asthenia, Cyanosis, Hypotonia, Peripheral Coldness
on Feb 18, 2010 Female patient from BULGARIA , 57 years of age, was diagnosed with breast cancer metastatic and was treated with Faslodex (View Usage). Patient experienced the following unwanted or unexpected effects: asthenia, cyanosis, hypotonia, peripheral coldness. Faslodex dosage: Two Consecutive 5 Ml Intramuscular Injections, One In Each Buttock.

6588363-2 | Amnesia, Decreased Appetite, Dyskinesia, Hot Flush, Hyperhidrosis, Influenza Like Illness, Injection Site Pain, Memory Impairment, Muscle Spasms
Patient was taking Faslodex (View Usage). Patient had the following side effects: amnesia, decreased appetite, dyskinesia, hot flush, hyperhidrosis, influenza like illness, injection site pain, memory impairment, muscle spasms on Feb 09, 2010 from UNITED STATES Additional patient health information: Female patient , 71 years of age, weighting 147.9 lb, was diagnosed with breast cancer metastatic and. Faslodex dosage: 2nd Dose Was 1/2 Of An Injection; Considering Full Dose For 3rd Dose. During the same period patient was treated with ZOLOFT (View Zoloft Review and Zoloft Label ), LEVOTHYROXINE SODIUM (View Levothyroxine Sodium Review and Levothyroxine Sodium Label ).

6585077-X | Skin Laceration, Syringe Issue
Adverse event was reported on Feb 08, 2010 by a Female patient taking Faslodex (View Usage) (Dosage: ) . Location: UNITED STATES , weighting 172.0 lb, After Faslodex was administered, patient had the following side effects: skin laceration, syringe issue.

6579379-0 | Biopsy Liver
on Feb 03, 2010 Female patient from AUSTRIA , weighting 178.6 lb, was diagnosed with breast cancer metastatic and was treated with Faslodex (View Usage). Patient experienced the following unwanted or unexpected effects: biopsy liver. Faslodex dosage: . Patient was hospitalized.

6577517-7 | Abdominal Discomfort, Ascites, Oedema Peripheral, Surgery, Weight Decreased
on Feb 02, 2010 Female patient from UNITED STATES , 76 years of age, weighting 104.9 lb, was diagnosed with breast cancer (What is breast cancer?) and was treated with Faslodex (View Usage). Patient had the following side effects: abdominal discomfort, ascites, oedema peripheral, surgery (What is surgery?), weight decreased. Faslodex dosage: One Injection.

6566531-3 | Injection Site Infection, Injection Site Necrosis
Patient was taking Faslodex (View Usage). After Faslodex was administered, patient had the following side effects: injection site infection, injection site necrosis on Jan 25, 2010 from UNITED STATES Additional patient health information: Female patient , 65 years of age, was diagnosed with neoplasm malignant and. Faslodex dosage: . Patient was hospitalized.

6549559-9 | Anaphylactic Reaction
Adverse event was reported on Jan 19, 2010 by a Female patient taking Faslodex (View Usage) (Dosage: ) . Location: GERMANY , weighting 163.1 lb, Patient experienced the following unwanted or unexpected effects: anaphylactic reaction. Patient was hospitalized.

6545119-4 | Pulmonary Embolism
on Jan 08, 2010 Female patient from CANADA , weighting 157.0 lb, was diagnosed with breast cancer (What is breast cancer?), hypertension, dyspepsia, abdominal discomfort, cough and was treated with Faslodex (View Usage). Patient had the following side effects: pulmonary embolism (What is pulmonary embolism?). Faslodex dosage: . During the same period patient was treated with CP 751,871 (View Cp-751,871 Review and Cp-751,871 Label ), AROMASIN (View Aromasin Review and Aromasin Label ), METOPROLOL (View Metoprolol Review and Metoprolol Label ), ZANTAC (View Zantac Review and Zantac Label ), REGLAN (View Reglan Review and Reglan Label ), ROBITUSSIN AC (View Robitussin Ac Review and Robitussin Ac Label ), MYLANTA (View Mylanta Review and Mylanta Label ). Patient was hospitalized.

6529958-1 | Skin Laceration, Syringe Issue
on Dec 29, 2009 Female patient from UNITED STATES , weighting 172.0 lb, was treated with Faslodex (View Usage). After Faslodex was administered, patient had the following side effects: skin laceration, syringe issue. Faslodex dosage: .

6420934-6 | Pulmonary Embolism
Patient was taking Faslodex (View Usage). Patient experienced the following unwanted or unexpected effects: pulmonary embolism (What is pulmonary embolism?) on Oct 22, 2009 from CROATIA (local name: Hrvatska) Additional patient health information: Female patient , weighting 176.4 lb, was diagnosed with breast cancer metastatic, metastases to bone and. Faslodex dosage: . During the same period patient was treated with PAMIDRONATE DISODIUM (View Pamidronate Disodium Review and Pamidronate Disodium Label ). Patient was hospitalized.

6406938-8 | Anaphylactic Reaction
Adverse event was reported on Sep 30, 2009 by a Female patient taking Faslodex (View Usage) (Dosage: 250 Mg/5ml One Per Month) was diagnosed with breast cancer (What is breast cancer?), metastases to bone, diabetes mellitus and. Location: RUSSIAN FEDERATION , weighting 216.1 lb, Patient had the following side effects: anaphylactic reaction. During the same period patient was treated with ZOMETA (View Zometa Review and Zometa Label ), DIABETON (View Diabeton Review and Diabeton Label ).

6405873-9 | Anaphylactic Reaction
on Sep 30, 2009 Female patient from RUSSIAN FEDERATION , weighting 216.1 lb, was diagnosed with breast cancer (What is breast cancer?), metastases to bone and was treated with Faslodex (View Usage). After Faslodex was administered, patient had the following side effects: anaphylactic reaction. Faslodex dosage: 250 Mg/5 Ml, 1 Df Per Month. During the same period patient was treated with ZOMETA (View Zometa Review and Zometa Label ), DIABETON (View Diabeton Review and Diabeton Label ).

6401749-1 | Phlebitis
on Oct 06, 2009 Female patient from FRANCE , weighting 152.1 lb, was diagnosed with breast cancer metastatic, glaucoma (What is glaucoma?), pain (What is pain?) and was treated with Faslodex (View Usage). Patient experienced the following unwanted or unexpected effects: phlebitis. Faslodex dosage: . During the same period patient was treated with DIAMOX SRC (View Diamox Src Review and Diamox Src Label ), OXYNORM (View Oxynorm Review and Oxynorm Label ), XALATAN (View Xalatan Review and Xalatan Label ), FORLAX (View Forlax Review and Forlax Label ). Patient was hospitalized.

6389570-4 | Anaphylactic Reaction
Patient was taking Faslodex (View Usage). Patient had the following side effects: anaphylactic reaction on Sep 30, 2009 from RUSSIAN FEDERATION Additional patient health information: Female patient , weighting 216.1 lb, was diagnosed with breast cancer (What is breast cancer?), metastases to bone, type 2 diabetes mellitus and. Faslodex dosage: 250 Mg/5 Ml, 1 Df Per Month. During the same period patient was treated with ZOMETA (View Zometa Review and Zometa Label ), DIABETON (View Diabeton Review and Diabeton Label ).